Noah Medical Corporation
USPTO PatentsView assignee record - 5 granted patents across 2 technology areas, recorded in grant years 2024–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Noah ranks #49,146 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 2 technology areas.
- #49,146
- of 49,997 US assignees by volume
- Top 47%
- by Innovation Score (36.2/100)
- 19.4
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R49146 · US Corporation #49,146 · 5 grants
GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH
- GRANTS-MICRO 5 grants
- BOTTOM-DECILE #49,146/49,997
- PHOTO-FINISH Nkia
- CPC-NARROW A61B · 2 areas
- INNOV-THIN 36.2/100
- CLAIMS-RICH 19.4 claims/avg
- TYPE-USCORP US Corporation
- SPAN-YRS 2024–2025 · 2y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: Nkia Co., Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Noah’s 36.2 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Noah
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Noah Medical · this assignee
Noah Medical · this assignee
36 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Noah's Innovation Score is 36.2/100 (top 47% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Noah?
Each dot is one of Noah’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Noah’s own 19.4 claims/patent is ABOVE the 11.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Noah's grants concentrate
Noah Medical Corporation is a focused PatentsView assignee: 2 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). By volume, Noah sits between Nkia Co., Ltd. and Noha, LLC.
Noah's three-year grant acceleration
Noah Medical Corporation shows 2 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Noah's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Nkia
Nkia Co., Ltd.
5 patents
- NKK Switches
NKK Switches Co., Ltd.
5 patents
- NLX
NLX Inc.
5 patents
- No-bull Enterpris…
No-bull Enterprises LLC
5 patents
- Noble Sensors
Noble Sensors, LLC
5 patents
- Nobotgames
Nobotgames, Inc.
5 patents
- Nodexus
Nodexus Inc.
5 patents
- Noha
Noha, LLC
5 patents
- Noah Medical ◀
Noah Medical Corporation
5 patents
What this shows Noah holds 5 patents at rank #49,052, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Noah
By rank, the assignees closest to #49,052 in granted patent volume.
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in Noah's primary technology class.
- Covidien LP 5,709 in class
- Koniniklijke Philips N.V. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag GmbH International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- DePuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Noah's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
36 Top 47% higher than 53% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2024–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2024 | 2 | 40.0% |
| 2025partial year | 3 | 60.0% |
Which technologies does Noah Medical Corporation patent most?
Top 2 of 2 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Noah Medical Corporation's patent record in context - here's where to go next.
- Noah Medical Corporation's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
- Ranked #49,146 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Noah Medical Corporation against Nkia Co., Ltd., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 36.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.